Intrinsic Therapeutics Debuts Barricaid Narrow Anchor Device

Intrinsic Therapeutics Barricaid Narrow Anchor

Intrinsic Therapeutics introduced the Barricaid Narrow Anchor, the next generation of its FDA PMA-approved Barricaid Bone-Anchored Annular Closure Device. The new version of the Barricaid device is 25% smaller than the standard Barricaid anchor.

This updated device is designed to make implantation easier by reducing bony removal and nerve...

document icon

You’ve reached your limit.

We’re glad you’re finding value in our content — and we’d love for you to keep going.

Subscribe now for unlimited access to orthopedic business intelligence.

JV

Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.



Contact Us

  • This field is for validation purposes and should be left unchanged.

0